Initially, it may seem as though life insurance does not have much impact on your estate plan. However, life insurance can be an integral, indispensably important part of a well-thought-out estate plan. There are numerous other benefits to owning a…
The number of patients living with Alzheimer’s disease is projected to rise sharply according to a study conducted by The Lewin Group of Falls Church, VA on the behalf of the Alzheimer’s Association. By the year 2040 more than twice…
Envision a time when you are no longer able to care for your sick spouse at home. At this emotionally difficult time, the last thing you need is the stress of not knowing where to find the money to pay…
There are more than 5 million Americans suffering from Alzheimer’s disease. Projections by the Alzheimer’s Association (alz.org) are that by 2050 more than 14 million Americans will suffer from this disease. What can you do if you are medically diagnosed…
As the baby boomers are getting ready to retire or have already retired, we are seeing a sharp increase in America’s elderly population. However, what has not been widely reported is how the rest of the nation will provide care…
In estate planning, it is common that parents divide the inheritance equally among the children. But sometimes, parents intentionally choose to not leave anything to a child, and the reasons for doing so may vary. One reason could be that…
Hospice care is meant to provide comfort by reducing suffering and focusing on the quality of life for the patient and the family. And yet a lack of regulation, oversight, and available information means that isn’t always the case. The…
Probate is the legal process of handling the estate of someone who has passed, where an executor assists in the distribution of the assets, clearing any debts, and finalizing any taxes owed in accordance with the will. To begin probate,…
You may have seen a friend or loved one suffer for a long time with Alzheimer’s. In the final stages of this and other dementia diseases, there comes a time when the person can no longer speak, recognize loved ones,…
The US Food and Drug Administration (FDA) recently approved a new drug under the trademark Aduhelm™ to treat Alzheimer’s disease. The drug, Aducanumab, is a therapeutic drug that clinically demonstrates a potential to delay further decline from Alzheimer’s disease and…
